Jennifer L Taylor Selected Research

Jennifer L Taylor Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 10/2008
9	Melanoma (Melanoma, Malignant) 01/2022 - 09/2003
5	Tuberculosis (Tuberculoses) 11/2012 - 04/2003
5	Infections 11/2012 - 04/2003
3	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2008
3	Carcinoma (Carcinomatosis) 01/2017 - 10/2008
3	Dyskinesias (Dyskinesia) 05/2006 - 08/2005
2	Vascular Tissue Neoplasms 11/2021 - 02/2012
2	Hyperoxia 01/2015 - 11/2014
2	Communicable Diseases (Infectious Diseases) 01/2014 - 12/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2014 - 10/2013
2	Disease Progression 01/2014 - 12/2008
2	Parkinson Disease (Parkinson's Disease) 11/2013 - 05/2006
2	Sarcoma (Soft Tissue Sarcoma) 07/2012 - 10/2008
2	Experimental Melanoma 02/2012 - 04/2011
2	Prostatic Neoplasms (Prostate Cancer) 12/2008 - 04/2005
1	Bites and Stings (Sting) 01/2021
1	Tertiary Lymphoid Structures 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2020
1	Atrophy 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Glomus Tumor (Glomus Tumors) 06/2015
1	Human Influenza (Influenza) 01/2014
1	Hypercapnia 05/2013
1	Latent Infection 11/2012
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2010
1	Tourette Syndrome (Tourette's Syndrome) 03/2010
1	Ovarian Neoplasms (Ovarian Cancer) 12/2008

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 11/2021 - 04/2003
10	AntigensIBA 11/2021 - 04/2011
8	Peptides (Polypeptides)IBA 11/2021 - 10/2008
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
5	ChemokinesIBA 01/2021 - 11/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2003
4	LigandsIBA 01/2014 - 12/2008
3	InterferonsIBA 11/2021 - 04/2011
3	EpitopesIBA 01/2014 - 12/2008
3	AerosolsIBA 11/2012 - 04/2003
3	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2012 - 12/2008
3	Dopamine (Intropin)FDA LinkGeneric 05/2006 - 08/2005
3	Levodopa (L Dopa)FDA LinkGeneric 05/2006 - 08/2005
2	IntegrinsIBA 01/2022 - 09/2008
2	Dasatinib (BMS 354825)FDA Link 11/2021 - 01/2014
2	CytokinesIBA 01/2021 - 02/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2014 - 12/2013
2	Phosphotransferases (Kinase)IBA 01/2014 - 12/2008
2	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 07/2012 - 09/2009
2	Interleukin-12 (IL 12)IBA 03/2012 - 04/2011
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 02/2012 - 04/2011
1	PeptidomimeticsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2022
1	ImmunosorbentsIBA 11/2021
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	EnzymesIBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	ElementsIBA 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2015
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2015
1	Growth Hormone (Somatotropin)IBA 01/2015
1	Glucagon (Glukagon)FDA Link 01/2015
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2014
1	HLA-DR Antigens (HLA-DR)IBA 01/2014
1	amsonic acid (DAS)IBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	EphrinsIBA 01/2014
1	Oxidants (Oxidizing Agents)IBA 12/2013
1	Therapeutic UsesIBA 11/2013
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2013
1	Vasodilator Agents (Vasodilators)IBA 05/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2012
1	Histocompatibility Antigens Class IIBA 02/2012
1	Blocking AntibodiesIBA 11/2011
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2011
1	OvalbuminIBA 11/2011
1	Sunitinib (Sutent)FDA Link 11/2011
1	InterleukinsIBA 04/2011
1	Haloperidol (Haldol)FDA LinkGeneric 03/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2010
1	2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA 03/2010
1	staphylococcal enterotoxin BIBA 12/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2009
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2009
1	Monoclonal AntibodiesIBA 09/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2008
1	Mitogen-Activated Protein KinasesIBA 12/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2006
6	Immunotherapy 01/2021 - 07/2012
2	Drug Therapy (Chemotherapy) 05/2006 - 09/2003
1	Precision Medicine 01/2022
1	Deep Brain Stimulation 11/2013
1	VAC combination 11/2011